Clinician shortages, telehealth growth fuel $12.3b AI virtual medical assistant market

Asia-Pacific is expected to be the fastest-growing regional market.

The global AI virtual medical assistant market is projected to grow from $2.6b in 2026 to $12.3b by 2031, according to Wissen Research.

Growth is being driven by demand for personalised healthcare support, remote patient engagement, and automation of routine clinical workflows.

AI-powered virtual medical assistants can support symptom assessment, appointment scheduling, medication reminders, and access to health information through conversational AI interfaces.

Healthcare providers are adopting the technology to reduce administrative workloads, improve patient communication, and strengthen care coordination. Advances in generative AI and natural language processing are also accelerating adoption alongside the wider expansion of telehealth.

The market is also being supported by clinician burnout and workforce shortages, as providers use AI to automate workflows and clinical documentation. The expansion of value-based care is increasing demand for AI-assisted clinical coding, while FHIR API integration is enabling virtual assistants to connect with existing electronic health record systems.

Demand for administrative automation, including prior authorisation, is also growing as providers seek to reduce delays in care.

Meanwhile, expectations for 24/7 patient support are driving the adoption of conversational AI across hospitals, clinics, and payer organisations.

Integration with wearables and connected health devices is further expanding the use of virtual assistants in remote patient monitoring, chronic disease management and preventive care.

However, adoption faces challenges including data privacy and cybersecurity risks, particularly because virtual assistants handle sensitive medical information. Providers must also ensure the accuracy, reliability, and safety of AI-generated responses.

Legacy healthcare IT systems, evolving AI governance rules, uncertain reimbursement policies, and concerns over excessive reliance on AI in clinical decision-making could also affect adoption.

Asia-Pacific is expected to be the fastest-growing regional market, supported by wider smartphone access, telemedicine adoption, and government investment in digital health infrastructure across China, India, Japan, South Korea, and Australia.